A short 6-month extension for emergency scheduling of fentanyl analogues, an update to Illegal Pill Presses: An Overlooked Threat to American Patients, and twenty more COVID fraud and medicine safety stories.[...]
The Partnership for Safe Medicines and the National Association of Drug Diversion Investigators have released an update to 2019’s Illegal Pill Presses: An Overlooked Threat to American Patients.
Since the initial report, fentanyl deaths are higher than ever and these pills – created by clandestine pill presses around the globe – continue to be sold on the streets and on the dark web.[...]
Shabbir Safdar, Executive Director of the Partnership for Safe Medicines, released the following statement today in response to Congressional actions to permanently scheduling illicitly manufactured and deadly fentanyl…[...]
ADAP Advocacy Association CEO Brandon M. Macsata wrote this editorial, which appeared on the AIDS Drug Assistance Program’s website on April 1, 2021.
The Association first warned constituents that counterfeit Symtuza had been distributed to three U.S. pharmacies in December 2020, when Janssen issued an alert.[...]
Learn why permanently scheduling fentanyl-related substances and analogues on Schedule I of the Controlled Substances Act is an important policy tool in the fight against fentanyl-laced counterfeit medicines.[...]